Modulation of dendritic cell and T cell cross-talk during aging: The potential role of checkpoint inhibitory molecules
MetadataShow full item record
© 2017 Elsevier B.V. Dendritic cells (DCs) undergo continuous changes throughout life, and there is evidence that elderly DCs have a reduced capacity to stimulate T cells, which may contribute to impaired anti-tumour immune responses in elderly people with cancer. Changes in checkpoint inhibitory molecules/pathways during aging may be one mechanism that impairs the ability of elderly DCs to activate T cells. However, little is currently known regarding the combined effects of aging and cancer on DC and T cell inhibitory molecules/pathways. In this review, we discuss our current understanding of the influence of aging and cancer on key DC and T cell inhibitory molecules/pathways, the potential underlying cellular and molecular mechanisms contributing to their modulation, and the possibility of therapeutically targeting inhibitory molecules in elderly cancer patients.
Showing items related by title, author, creator and subject.
Fox, Simon; Richards, Alex; Kusumah, Ivonne; Perumal, Vanathi; Bolitho, Erin; Mutsaers, S.; Dharmarajan, A. (2013)Malignant mesothelioma (MM) is an uncommon and particularly aggressive cancer associated with 29asbestos exposure, which currently presents an intractable clinical challenge. Wnt signaling has been reported to play a role ...
Small molecule sensitization to TRAIL is mediated via nuclear localization, phosphorylation and inhibition of chaperone activity of Hsp27Mellier, G.; Liu, D.; Bellot, G.; Lisa Holme, A.; Pervaiz, Shazib (2013)The small chaperone protein Hsp27 confers resistance to apoptosis, and therefore is an attractive anticancer drug target. We report here a novel mechanism underlying the tumor necrosis factor-related apoptosis-inducing ...
Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticlesLee, A.; Dhillon, S.; Wang, Y.; Pervaiz, Shazib; Fan, W.; Yang, Y. (2011)The use of small molecule drugs in cancer chemotherapy has mostly been limited by dose-dependent toxicity and development of drug resistance resulting from repeated administrations. To overcome such problems, efforts have ...